Abstract
Goiters tend to grow slowly and steadily over many years, occasionally reaching the mediastinum and extending through the thoracic inlet into the visceral compartment. In most cases, retrosternal goiters originate from the cervical portion of the thyroid. The incidence of retrosternal goiters varies considerably, ranging from 0.2 to 45% of all thyroidectomies, depending on the criteria used to define this type of goiter. Symptoms are generally related to the compressive nature of the mass on the adjacent structures, and most patients report some form of respiratory manifestation associated with the goiter. A diagnostic assessment usually includes an evaluation of thyroid function, chest radiography, and computed tomography. Fine-needle aspiration biopsy should be avoided in substernal areas of the goiter due to limited visibility and location of vital structures in this region. Treatment of retrosternal goiters is surgical, as medical therapy is generally unsuccessful in these cases.
Similar content being viewed by others
References
Knobel M (2016) Etiopathology, clinical features, and treatment of diffuse and multinodular nontoxic goiters. J Endocrinol Invest 39:357–373
Haller A (1749) Disputationes anatomica selectae. Vandenhoeck, Gottingen, p 96
Doulaptsi M, Karatzanis A, Prokopakis E, Velegrakis S, Loutsidi A, Trachalaki A et al (2019) Substernal goiter: treatment and challenges. Twenty-two years of experience in diagnosis and management of substernal goiters. Auris Nasus Larynx 46:246–251
Simó R, Nixon IJ, Poorten VV et al (2019) Surgical management of substernal goiters. Eur Arch Otorhinolaryngol 276:305–314
Rios A, Rodriguez JM, Balsalobre MB, Tebar FJ, Parrilla P (2010) The value of various definitions of substernal goiter for predicting intra-operative and postoperative complications. Surgery 147:233–238
Lahey FH (1920) Diagnosis and management of intrathoracic goiter. JAMA 75:163–166
Crile G (1939) Intrathoracic goiter. Cleve Clin Q 6:313–322
Lindskog GE, Goldenberg IS (1957) Differential diagnosis, pathology, and treatment of substernal goiter. JAMA 163:527–529
Katlic MR, Wang CA, Grillo HC (1985) Substernal goiter. Ann Thorac Surg 39:391–399
Dahan M, Guillard J, Eschapase H (1989) Surgical treatment of goiters with intrathoracic development. In: Delarue NC, Eschapase H (eds) Thoracic surgery: frontiers and uncommon neoplasms. International trends in general thoracic surgery. Mosby, St Louis
Torre G, Borgonovo G, Amato A, Arezzo A, Ansaldo G, De Negri A et al (1995) Surgical management of substernal goiter: analysis of 237 patients. Am Surg 61:826–831
Modlin IM (1998) Surgical triumvirate of Theodor Kocher, Harvey Cushing, and William Halsted. World J Surg 22:103–113
Netterville JL, Coleman SC, Smith JC, Smith MM, Day TA, Burkey BB (1998) Management of substernal goiter. Laryngoscope 108:1611–1617
Hsu B, Reeve TS, Guinea AI, Robinson B, Delbridge L (1996) Recurrent substernal nodular goiter: incidence and management. Surgery 120:1072–1075
Sancho JJ, Kraimps JL, Sanchez-Blanco JM, Larrad A, Rodríguez JM, Gil P et al (2006) Increased mortality and morbidity associated with thyroidectomy for intrathoracic goiters reaching the carina tracheae. Arch Surg 141:82–85
Chen AY, Bernet VJ, Carty SE, Davies TF, Ganly I, Inabnet WB et al (2014) American Thyroid Association statement on optimal surgical management of goiter. Thyroid 24:181–189
Newman E, Shaha AR (1995) Substernal goiter. J Surg Oncol 60:207–212
Raffaelli M, De Crea C, Ronti S, Bellantone R, Lombardi CP (2011) Substernal goiters: incidence, surgical approach, and complications in a tertiary care referral center. Head Neck 33:1420–1425
Madjar S, Weissberg D (1995) Retrosternal goiter. Chest 108:78–82
De Andrade MA (1977) A review of 128 cases of posterior mediastinal goiter. World J Surg 1:789–797
Ben Nun A, Soudack M, Best LA (2006) Retrosternal thyroid goiter: 15 years experience. Isr Med Assoc J 8:106–109
Huins CT, Georgalas C, Mehrzad H et al (2008) A new classification system for retrosternal goiter based on a systematic review of its complications and management. Int J Surg 6:71–76
Lin YS, Wu HY, Lee CW, Hsu CC, Chao TC, Yu MC (2016) Surgical management of substernal goitres at a tertiary referral centre: a retrospective cohort study of 2104 patients. Int J Surg 27:46–52
Knudsen N, Bülow I, Jorgensen T, Laurberg P, Ovesen L, Perrild H (2000) Goitre prevalence and thyroid abnormalities at ultrasonography: a comparative epidemiological study in two regions with slightly different iodine status. Clin Endocrinol (Oxf) 53:479–485
Hansen PS, Brix TH, Bennedbaek FN, Bonnema SJ, Iachine I, Kyvik KO, Hegedüs L (2005) The relative importance of genetic and environmental factors in the etiology of thyroid nodularity: a study of healthy Danish twins. Clin Endocrinol (Oxf) 62:380–386
Mack E (1995) Management of patients with substernal goiters. Surg Clin N Am 75:377–394
White ML, Doherty GM, Gauger PG (2008) Evidence-based surgical management of substernal goiter. World J Surg 32:1285–1300
Marqusee E, Benson CB, Frates MC, Doubilet PM, Larsen PR, Cibas ES et al (2000) Usefulness of ultrasonography in the management of nodular thyroid disease. Ann Intern Med 133:696–700
Di Crescenzo V, Vitale M, Valvano L, Napolitano F, Vatrella A, Zeppa P et al (2016) Surgical management of cervico-mediastinal goiters: our experience and review of the literature. Int J Surg 28(Suppl 1):S47–53
Sahbaz NA, Total F, Aksakal N, Acar S, Aksu KI, Barbaros U, Erbil Y (2017) Cancer frequency in retrosternal goiter. Am Surg 83:1390–1393
Allo MD, Thompson NW (1983) Rationale for the operative management of substernal goiters. Surgery 94:969–977
Michel LA, Bradpiece HA (1988) Surgical management of substernal goiter. Br J Surg 75:565–569
Sanders LE, Rossi RL, Shahian DM et al (1992) Mediastinal goiters: the need for an aggressive approach. Arch Surg 127:609–613
Cho HT, Cohen JP, Som ML (1986) Management of substernal and intrathoracic goiters. Otolaryngol Head Neck Surg 94:282–287
Derwahl M, Studer H (2000) Multinodular goiter: “much more to It than simply iodine deficiency”. Baillieres Best Pract Res Clin Endocrinol Metab 14:577–660
Derwahl M, Studer H (2002) Hyperplasia versus adenoma in endocrine tissues: are they different. Trends Endocrinol Metab 13:23–28
Bizakis J, Karatzanis A, Hajiioannou J, Bourolias C, Maganas E, Spanakis E et al (2008) Diagnosis and management of substernal goiter at the University of Crete. Surg Today 38:99–103
Rodrigues MG, Filho VJFA, Matos LL, Hojaij FC, Simões CA, Araujo VJFN et al (2017) Substernal goiter and laryngopharyngeal reflux. Arch Endocrinol Metab 61:348–353
Mönkemüller K, Poppen D, Feldmann K, Ulbricht LJ (2010) Downhill varices resulting from giant intrathoracic goiter. Endoscopy 42(Suppl 2):E40
Lucchini R, Santoprete S, Triola R, Polistena A, Monacelli M, Avenia S et al (2015) Tracheal varices caused by mediastinal compression of a large intrathoracic goiter: report of a case G. Chir 36:26–28
Anders HJ (1998) Compression syndromes caused by substernal goiters. Postgrad Med J 74:327–329
Shen WT, Kebebew E, Duh QY, Clark OH (2004) Predictors of airway complications after thyroidectomy for substernal goiter. Arch Surg 139:656–659
Maruotti RA, Zannini P, Viani MP, Voci C, Pezzuoli G (1991) Surgical treatment of substernal goiters. Int Surg 76:12–17
Al-Bazzaz F, Grillo H, Kazemi H (1975) Response to exercise in upper airway obstruction. Am Rev Respir Dis 111:631–640
Lamke LO, Bergdahl L, Lamke B (1979) Intrathoracic goitre: a review of 29 cases. Acta Chir Scand 145:83–86
Fast S, Bonnema SJ, Hegedüs L (2008) The majority of Danish nontoxic goitre patients are ineligible for Levothyroxine suppressive therapy. Clin Endocrinol (Oxf) 69:653–658
Park HM, Tarver RD, Siddiqui AR, Schauwecker DS, Wellman HN (1987) Efficacy of thyroid scintigraphy in the diagnosis of intrathoracic goiter. Efficacy of thyroid scintigraphy in the diagnosis of intrathoracic goiter. Am J Roentgenol 148:527–529
Cibas ES, Ali SZ (2009) The Bethesda System for reporting thyroid cytopathology. Thyroid 19:1159–1165
Macerola E, Rago T, Proietti A, Basolo F, Vitti P (2019) The mutational analysis in the diagnostic work-up of thyroid nodules: the real impact in a center with large experience in thyroid cytopathology. J Endocrinol Invest 42:157–166
Muzza M, Colombo C, Pogliaghi G, Karapanou O, Fugazzola L (2020) Molecular markers for the classification of cytologically indeterminate thyroid nodules. J Endocrinol Invest 43:703–716
Ho AS, Sarti EE, Jain KS, Wang H, Nixon IJ, Shaha AR et al (2014) Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS). Thyroid 24:832–839
Roth MY, Witt RL, Steward DL (2018) Molecular testing for thyroid nodules: review and current state. Cancer 124:888–898
Miller MR, Pincock AC, Oates GD, Wilkinson R, Skene-Smith H (1990) Upper airway obstruction due to goitre: detection, prevalence and results of surgical management. Q J Med 74:177–188
Priola AM, Priola SM, Cardinale L, Cataldi A, Fava C (2006) The anterior mediastinum: diseases. Radiol Med 111:312–342
Carter BW, Marom EM, Detterbeck FC (2014) Approaching the patient with an anterior mediastinal mass: a guide for clinicians. J Thorac Oncol 9(9 Suppl 2):S102–S109
Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Yuri E et al (2016) 2015 American Thyroid Association Management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer. Thyroid 26:1–133
Hegedüs L, Bonnema SJ (2010) Approach to management of the patient with primary or secondary intrathoracic goiter. J Clin Endocrinol Metab 95:5155–5162
Bonnema SJ, Bertelsen H, Mortensen J, Andersen PB, Knudsen DU, Bastholt L, Hegedüs L (1999) The feasibility of high dose iodine 131 treatment as an alternative to surgery in patients with a very large goiter: effect on thyroid function and size and pulmonary function. J Clin Endocrinol Metab 84:3636–3641
Huysmans DA, Hermus AR, Corstens FH, Barentsz JO (1994) Kloppenborg PW 1994 Large, compressive goiters treated with radioiodine. Ann Intern Med 121:757–762
Fast S, Nielsen VE, Bonnema SJ, Hegedüs L (2009) Time to reconsider nonsurgical therapy of benign non-toxic multinodular goitre: focus on recombinant human TSH augmented radioiodine therapy. Eur J Endocrinol 160:517–528
Bonnema SJ, Hegedüs L (2009) A 30-year perspective on radioiodine therapy of benign nontoxic multinodular goiter. Curr Opin Endocrinol Diabetes Obes 16:379–384
Medeiros-Neto G, Marui S, Knobel M (2008) An outline concerning the potential use of recombinant human thyrotropin for improving radioiodine therapy of multinodular goiter. Endocrine 33:109–117
Bonnema SJ, Nielsen VE, Boel-Jørgensen H, Grupe P, Andersen PB, Bastholt L, Hegedüs L (2007) Improvement of goiter volume reduction after 0.3 mg recombinant human thyrotropin-stimulated radioiodine therapy in patients with a very large goiter: a double-blinded, randomized trial. J Clin Endocrinol Metab 92:3424–3428
Fast S, Nielsen VE, Grupe P, Bonnema SJ, Hegedüs L (2009) Optimizing 131I uptake after rhTSH stimulation in patients with nontoxic multinodular goiter: evidence from a prospective, randomized, double-blind study. J Nucl Med 50:732–737
Nielsen VE, Bonnema SJ, Boel-Jørgensen H, Grupe P, Hegedüs L (2006) Stimulation with 0.3-mg recombinant human thyrotropin prior to iodine 131 therapy to improve the size reduction of benign nontoxic nodular goiter: a prospective randomized, double-blind trial. Arch Intern Med 166:1476–1482
Fast S, Hegedüs L, Grupe P, Nielsen VE, Bluhme C, Bastholt L, Bonnema SJ (2010) Recombinant human thyrotropin-stimulated radioiodine therapy of nodular goiter allows major reduction of the radiation burden with retained efficacy. J Clin Endocrinol Metab 95:3719–3725
Bonnema SJ, Nielsen VE, Boel-Jørgensen H, Grupe P, Andersen PB, Bastholt L, Hegedüs L (2008) Recombinant human thyrotropin-stimulated radioiodine therapy of large nodular goiters facilitates tracheal decompression and improves inspiration. J Clin Endocrinol Metab 93:3981–3984
Yoldas T, Makay O, Icoz G, Kose T, Gezer G, Kismali E, Tamsel S, Ozbek S, Yılmaz M, Akyildiz M (2015) Should subtotal thyroidectomy be abandoned in multinodular goiter patients from endemic regions requiring surgery? Int Surg 100:9–14
Testini M, Gurrado A, Avenia N, Bellantone R, Biondi A, Brazzarola P et al (2011) Does mediastinal extension of the goiter increase morbidity of total thyroidectomy? A multicenter study of 19,662 patients. Ann Surg Oncol 18:2251–2259
Moten AS, Thibault DP, Willis AW, Willis AI (2016) Demographics, disparities, and outcomes in substernal goiters in the United States. Am J Surg 211:703–709
Erbil Y, Bozbora A, Barbaros U, Ozarmağan S, Azezli A, Molvalilar S (2004) Surgical management of substernal goiters: clinical experience of 170 cases. Surg Today 34:732–736
Hanson MA, Shaha AR, Wu JX (2019) Surgical approach to the substernal goiter. Best Pract Res Clin Endocrinol Metab 33:101312
Materazzi G, Fregoli L, Papini P et al (2018) Robot-assisted transaxillary thyroidectomy (RATT): a series appraisal of more than 250 cases from Europe. World J Surg 42:1018–1023
Shaha AR (2015) Transaxillary thyroidectomy—a critical appraisal. J Surg Oncol 111:131–132
Prete FP, Marzaioli R, Lattarulo S, Paradies D, Barile G, d'Addetta MV et al (2019) Transaxillary robotic-assisted thyroid surgery: technique and results of a preliminary experience on the Da Vinci Xi platform. BMC Surg 18(Suppl1):19
Miccoli P, Fregoli L, Rossi L, Papini P, Ambrosini CE, Bakkar S et al (2020) Minimally invasive video-assisted thyroidectomy (MIVAT). Gland Surg 9(Suppl 1):S1–S5
Dionigi G, Dralle H, Materazzi G, Kim HY, Miccoli P (2020) Happy 20th birthday to minimally invasive video-assisted thyroidectomy! J Endocrinol Invest 43:385–388
Piao M, Yuan Y, Wang Y, Feng C (2013) Successful management of trachea stenosis with massive substernal goiter via thacheobronchial stent. J Cardiothorac Surg 8:212
Miccoli P, Antonelli A, Iacconi P, Alberti B, Gambuzza C, Baschieri L (1993) Prospective, randomized, double-blind study about effectiveness of levothyroxine suppressive therapy in prevention of recurrence after operation: result at the third year of follow-up. Surgery 114:1097–1101
Rojdmark J, Jarhult J (1995) High long term recurrence rate after subtotal thyroidectomy for nodular goiter. Eur J Surg 161:725–727
Acknowledgements
The author would like to thank Milena Braga-Basaria M.D. for editorial suggestions and revision of the manuscript.
Author information
Authors and Affiliations
Contributions
The author confirms being the sole contributor to this work and approved it for publication.
Corresponding author
Ethics declarations
Conflict of interest
The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Ethical approval
This review did not include studies conducted by the author with the participation of humans or animals.
Informed consent
For this type of article, a formal consent is not required.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Knobel, M. An overview of retrosternal goiter. J Endocrinol Invest 44, 679–691 (2021). https://doi.org/10.1007/s40618-020-01391-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40618-020-01391-6